| __timestamp | ACADIA Pharmaceuticals Inc. | Insmed Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 56292000 |
| Thursday, January 1, 2015 | 73869000 | 74277000 |
| Friday, January 1, 2016 | 99284000 | 122721000 |
| Sunday, January 1, 2017 | 149189000 | 109749000 |
| Monday, January 1, 2018 | 187163000 | 145283000 |
| Tuesday, January 1, 2019 | 240385000 | 131711000 |
| Wednesday, January 1, 2020 | 319130000 | 181157000 |
| Friday, January 1, 2021 | 239415000 | 272744000 |
| Saturday, January 1, 2022 | 361575000 | 397518000 |
| Sunday, January 1, 2023 | 351619000 | 571011000 |
Data in motion
In the ever-evolving landscape of biopharmaceuticals, research and development (R&D) investments are pivotal. Over the past decade, Insmed Incorporated and ACADIA Pharmaceuticals Inc. have demonstrated significant commitment to innovation. From 2014 to 2023, Insmed's R&D expenses surged by over 900%, peaking in 2023 with a remarkable 571 million dollars. Meanwhile, ACADIA's R&D investments grew by approximately 480%, reaching their zenith in 2022. This trend underscores the industry's relentless pursuit of groundbreaking therapies. Notably, Insmed's R&D spending surpassed ACADIA's in recent years, highlighting its aggressive strategy in drug development. As these companies continue to invest heavily in R&D, they not only drive their own growth but also contribute to the broader advancement of medical science. This data offers a glimpse into the strategic priorities shaping the future of healthcare.
Analyzing R&D Budgets: Johnson & Johnson vs Insmed Incorporated
R&D Spending Showdown: Novartis AG vs ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Sanofi and Insmed Incorporated
Bristol-Myers Squibb Company or Insmed Incorporated: Who Invests More in Innovation?
Gilead Sciences, Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending
Gilead Sciences, Inc. vs ACADIA Pharmaceuticals Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Regeneron Pharmaceuticals, Inc. and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ACADIA Pharmaceuticals Inc.
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending